Developer docs
API playgroundTry for free, no card

Search company profiles

Idil Biotech

Full company profile

uuid000pal3

Namestring
Idil Biotech
Legal namestring
İdil Biotech
Websiteurl
idilbiotech.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Idil Biotech (legal name İdil Biotech) is a privately held medical diagnostic company headquartered in TÜBİTAK Marmara Teknokent, Gebze, Kocaeli, Turkey, founded in 2019 by individuals with more than 20 years of experience in molecular in vitro diagnostics. The company develops, manufactures, and markets real-time PCR (qPCR) diagnostic kits under the RevoDx brand, organized into clinically specific panels covering high-risk viral pathogens, sexually transmitted infections, respiratory infections, gastrointestinal pathogens, bacterial, viral, fungal, and protozoan infections, sepsis, meningitis/encephalitis, transplant, TORCH, tropical, herpes virus, and HLA genetic testing, alongside a SARS-CoV-2 dual-target kit. Its technology stack centers on probe- and dye-based qPCR compatible with most commercial real-time PCR instruments, paired with the DirEXT sub-brand of silica spin-column and magnetic-bead nucleic acid extraction reagents and a line of qPCR master mixes for research use. Manufacturing is conducted under ISO 13485 quality management in accordance with IVDD and IVDR, with CE-IVD marked products.

The company operates four revenue streams: (1) direct B2B sales of RevoDx diagnostic kits to clinical laboratories and hospital diagnostic departments (sold in standardized 100- or 500-test packages at undisclosed list prices via direct sales contact), (2) RevoDx/DirEXT purification and sample preparation kit sales, (3) contract manufacturing and outsourcing services for molecular diagnostic solutions (concept design, assay development, prototype and pilot batch production, validation and stability studies, technical documentation, CE submission assistance), and (4) OEM partnerships and technology transfer for products in its portfolio. Go-to-market is enterprise field sales supplemented by international trade show presence at Medlab Middle East, MEDICA, ECCMID, and Expomed Eurasia, and a product-catalog-driven company website. Customer concentration is not publicly disclosed; the named customer segments are clinical laboratories/hospitals (primary) and medical technology/biotechnology companies seeking outsourcing or OEM arrangements (secondary).

Short descriptiontext

Idil Biotech is a Turkey-based IVD manufacturer that develops and markets RevoDx real-time PCR diagnostic kits for infectious disease detection, serving clinical laboratories, hospitals, and medtech companies via direct B2B sales, OEM partnerships, and contract manufacturing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersIstanbul
HQ citystring
Istanbul
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostic kits, real-time PCR reagents, infectious disease detection, in vitro diagnostics, nucleic acid extraction
Industry3 codes
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAAALAC
Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Molecular Diagnostics (In Vitro Diagnostics)
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Diagnostic Kit Sales
TypeOne Time License
Description

Sale of RevoDx brand molecular diagnostic kits for detection of various pathogens. Products are sold in test kit formats (typically 100 or 500 tests per kit) with catalog numbers for ordering.

idilbiotech.com
2Purification Kit Sales
TypeOne Time License
Description

Sale of nucleic acid extraction and purification kits for sample preparation in molecular diagnostics.

idilbiotech.com
3Outsourcing Services
TypeProfessional Services
Description

Contract manufacturing and outsourcing services for molecular diagnostic solutions including assay design, manufacturing of prototypes and pilot batches, validation and stability studies, technical documentation, and certification assistance for CE submissions.

idilbiotech.com
4OEM Partnership
TypeLicensing Royalties
Description

Technology transfer and OEM partnership for products in the portfolio, allowing other companies to manufacture or distribute Idil Biotech products.

idilbiotech.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
Pricing details1 tier
1Research and diagnostic kits sold in standard package sizes
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products typically sold in 100-test or 500-test packages with specific catalog numbers. Example: RevoDx CMV qPCR Kit available in 100 tests (IP201904-100) or 250 tests (IP201904-250). Direct customer contact required for pricing.

idilbiotech.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1RevoDx
Description

Molecular diagnostic product brand encompassing qPCR kits for infectious disease detection including viral, bacterial, fungal, and parasitic pathogens. Products include RevoDx SARS-CoV-2 qPCR Kit, RevoDx Respiratory-24 Pathogen Detection Kit, RevoDx Gastro Pathogen Detection Kit, RevoDx STI Pathogen Detection Kit, RevoDx Sepsis Pathogen Detection Kit, and many more diagnostic kits.

idilbiotech.com
+1 more record
Core offering1 text field

Idil Biotech develops, manufactures, and sells the RevoDx brand of real-time PCR (qPCR) molecular diagnostic kits for detection of infectious disease pathogens (viruses, bacteria, fungi, parasites) across panels for high-risk viral pathogens, STIs, respiratory, gastrointestinal, sepsis, meningitis/encephalitis, transplant, TORCH, tropical diseases, herpes, HLA genetics, and drug resistance. The company also markets DirEXT nucleic acid extraction/purification reagents, qPCR research master mixes, and offers contract manufacturing, assay development, validation, and OEM technology transfer services to other diagnostics companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • CMV qPCR Kit Limit of Detection: 56 IU/mL
+3 more records
Product overview1 text field

Idil Biotech is a medical diagnostic company providing high-value molecular diagnostic solutions for infectious diseases. The company's product portfolio centers on the RevoDx brand of real-time PCR (qPCR) diagnostic kits, encompassing over 100+ individual products organized into disease-specific categories. The portfolio includes: high-risk viral pathogen kits (HBV, HCV, HIV), sexually transmitted infection panels, respiratory pathogen panels (ranging from Respiratory-5 to Respiratory-34), gastrointestinal pathogen detection kits (bacterial, viral, parasitic), bacterial/viral/fungal/protozoan pathogen kits, drug resistance detection kits, herpes virus kits, HLA genetic testing kits, transplant pathogen panels, TORCH panels, sepsis and meningitis/encephalitis kits, tropical disease kits, SARS-CoV-2 kits, and sample preparation/purification products. The company also offers contract manufacturing and outsourcing services for molecular diagnostics development.

Product and service1 record
1RevoDx High Risk Viral Pathogen Detection Kits
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Idil Biotech offers comprehensive outsourcing services for molecular diagnostic solutions to medical technology and biotechnology companies. Services include concept design, assay development, manufacturing of prototypes and pilot batches, validation and stability studies, technical documentation, and certification assistance for CE submissions. Technology transfer of products in the portfolio is also possible.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Turkey-based molecular diagnostics company offering a broad IVD/CE-marked qPCR menu for infectious disease pathogens, HLA typing, and HPV genotyping - the closest head-to-head peer to Idil Biotech given shared geography, technology platform, and target customer (clinical labs in EMEA/Middle East).

2Seegene
TypeDirect peer
Description

Korean molecular diagnostics specialist known for multiplex syndromic qPCR panels (respiratory, gastro, STI, meningitis/encephalitis) sold under its own brand and widely OEM-licensed - directly comparable to Idil's RevoDx multiplex pathogen panels on technology, menu, and OEM go-to-market model.

TypeDirect peer
Description

Turkey-based molecular diagnostics company producing CE-IVD qPCR kits and rapid molecular platforms (including the COVID-era Rapid Molecular Detection System) - directly comparable given shared Turkish base, IVD/CE-IVD positioning, and infectious disease menu overlap with RevoDx.

TypeDirect peer
Description

European IVD manufacturer with a real-time PCR infectious disease menu, sample-preparation kits, and OEM/private-label capabilities - directly comparable to Idil on product architecture (qPCR kits + extraction reagents), CE-IVD positioning, and OEM contract manufacturing services.

TypeDirect peer
Description

Italy-based molecular diagnostics company selling CE-IVD qPCR kits for infectious diseases (HBV, HCV, HIV, STI, respiratory, meningitis) plus OEM manufacturing services - closely comparable mid-sized European peer with similar menu breadth and OEM go-to-market.

TypeBroad incumbent
Description

Berlin-based molecular diagnostics specialist (now part of Roche Diagnostics) historically known for rapid development of qPCR assays for emerging pathogens and a deep infectious-disease menu - comparable on assay design philosophy and pathogen menu, though now distributed through Roche's global commercial engine.

TypeBroad incumbent
Description

Italian-headquartered diagnostics multinational with a molecular business spanning qPCR kits, sample-to-answer systems (LIAISON MDX), and OEM partnerships - comparable on molecular IVD menu and EMEA footprint, though operating at much larger scale with proprietary instrumentation.

TypeEmerging player
Description

Spain-based molecular diagnostics and microbiology company offering qPCR infectious-disease kits and OEM capabilities - comparable European mid-market peer with overlapping IVD/CE-IVD molecular menu and similar reliance on distribution partners.

TypeBroad incumbent
Description

Global molecular diagnostics and sample-preparation leader with the artus/QuantiFERON/QIAsymphony portfolio - overlaps with Idil on nucleic acid extraction kits (DirEXT vs QIAamp) and on parts of the infectious-disease qPCR menu, while operating at vastly larger scale through proprietary automation.

TypeEmerging player
Description

Korean molecular diagnostics manufacturers producing CE-IVD/KFDA qPCR kits for infectious diseases (including SARS-CoV-2, respiratory, and enteric pathogens) and exporting globally - similar-sized Asian peers competing in the same overseas tender markets as Idil Biotech.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Idil Biotech

Molecular Diagnostics (In Vitro Diagnostics)idilbiotech.com

Idil Biotech is a Turkey-based IVD manufacturer that develops and markets RevoDx real-time PCR diagnostic kits for infectious disease detection, serving clinical laboratories, hospitals, and medtech companies via direct B2B sales, OEM partnerships, and contract manufacturing.

What Idil Biotech does

Idil Biotech (legal name İdil Biotech) is a privately held medical diagnostic company headquartered in TÜBİTAK Marmara Teknokent, Gebze, Kocaeli, Turkey, founded in 2019 by individuals with more than 20 years of experience in molecular in vitro diagnostics. The company develops, manufactures, and markets real-time PCR (qPCR) diagnostic kits under the RevoDx brand, organized into clinically specific panels covering high-risk viral pathogens, sexually transmitted infections, respiratory infections, gastrointestinal pathogens, bacterial, viral, fungal, and protozoan infections, sepsis, meningitis/encephalitis, transplant, TORCH, tropical, herpes virus, and HLA genetic testing, alongside a SARS-CoV-2 dual-target kit. Its technology stack centers on probe- and dye-based qPCR compatible with most commercial real-time PCR instruments, paired with the DirEXT sub-brand of silica spin-column and magnetic-bead nucleic acid extraction reagents and a line of qPCR master mixes for research use. Manufacturing is conducted under ISO 13485 quality management in accordance with IVDD and IVDR, with CE-IVD marked products.

The company operates four revenue streams: (1) direct B2B sales of RevoDx diagnostic kits to clinical laboratories and hospital diagnostic departments (sold in standardized 100- or 500-test packages at undisclosed list prices via direct sales contact), (2) RevoDx/DirEXT purification and sample preparation kit sales, (3) contract manufacturing and outsourcing services for molecular diagnostic solutions (concept design, assay development, prototype and pilot batch production, validation and stability studies, technical documentation, CE submission assistance), and (4) OEM partnerships and technology transfer for products in its portfolio. Go-to-market is enterprise field sales supplemented by international trade show presence at Medlab Middle East, MEDICA, ECCMID, and Expomed Eurasia, and a product-catalog-driven company website. Customer concentration is not publicly disclosed; the named customer segments are clinical laboratories/hospitals (primary) and medical technology/biotechnology companies seeking outsourcing or OEM arrangements (secondary).

Idil Biotech firmographics

Firmographics
Name
Idil Biotech
Legal name
İdil Biotech
Website
https://idilbiotech.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
Idil Biotech is a Turkey-based IVD manufacturer that develops and markets RevoDx real-time PCR diagnostic kits for infectious disease detection, serving clinical laboratories, hospitals, and medtech companies via direct B2B sales, OEM partnerships, and contract manufacturing.
Ownership category
akta.pro rank

Idil Biotech industry classification

Industry
Product category
Molecular Diagnostics (In Vitro Diagnostics)
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAAALAC
Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)

Keywords

  • Molecular diagnostic kits
  • Real-time PCR reagents
  • Infectious disease detection
  • In vitro diagnostics
  • Nucleic acid extraction

Where Idil Biotech is headquartered

Location

Headquarters

HQ city
Istanbul

Offices2 records

Markets served

Idil Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Diagnostic Kit Sales: Sale of RevoDx brand molecular diagnostic kits for detection of various pathogens. Products are sold in test kit formats (typically 100 or 500 tests per kit) with catalog numbers for ordering.
  2. Purification Kit Sales: Sale of nucleic acid extraction and purification kits for sample preparation in molecular diagnostics.
  3. Outsourcing Services: Contract manufacturing and outsourcing services for molecular diagnostic solutions including assay design, manufacturing of prototypes and pilot batches, validation and stability studies, technical documentation, and certification assistance for CE submissions.
  4. OEM Partnership: Technology transfer and OEM partnership for products in the portfolio, allowing other companies to manufacture or distribute Idil Biotech products.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goResearch and diagnostic kits sold in standard package sizes

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Idil Biotech product offering

Product offering

Core offering

Idil Biotech develops, manufactures, and sells the RevoDx brand of real-time PCR (qPCR) molecular diagnostic kits for detection of infectious disease pathogens (viruses, bacteria, fungi, parasites) across panels for high-risk viral pathogens, STIs, respiratory, gastrointestinal, sepsis, meningitis/encephalitis, transplant, TORCH, tropical diseases, herpes, HLA genetics, and drug resistance. The company also markets DirEXT nucleic acid extraction/purification reagents, qPCR research master mixes, and offers contract manufacturing, assay development, validation, and OEM technology transfer services to other diagnostics companies.

Product overview

Idil Biotech is a medical diagnostic company providing high-value molecular diagnostic solutions for infectious diseases. The company's product portfolio centers on the RevoDx brand of real-time PCR (qPCR) diagnostic kits, encompassing over 100+ individual products organized into disease-specific categories. The portfolio includes: high-risk viral pathogen kits (HBV, HCV, HIV), sexually transmitted infection panels, respiratory pathogen panels (ranging from Respiratory-5 to Respiratory-34), gastrointestinal pathogen detection kits (bacterial, viral, parasitic), bacterial/viral/fungal/protozoan pathogen kits, drug resistance detection kits, herpes virus kits, HLA genetic testing kits, transplant pathogen panels, TORCH panels, sepsis and meningitis/encephalitis kits, tropical disease kits, SARS-CoV-2 kits, and sample preparation/purification products. The company also offers contract manufacturing and outsourcing services for molecular diagnostics development.

Differentiator

Problem solved

Functional benefit

Brands

  • RevoDx: Molecular diagnostic product brand encompassing qPCR kits for infectious disease detection including viral, bacterial, fungal, and parasitic pathogens. Products include RevoDx SARS-CoV-2 qPCR Kit, RevoDx Respiratory-24 Pathogen Detection Kit, RevoDx Gastro Pathogen Detection Kit, RevoDx STI Pathogen Detection Kit, RevoDx Sepsis Pathogen Detection Kit, and many more diagnostic kits.
  • DirEXT

Products and services

  • RevoDx High Risk Viral Pathogen Detection Kits

Quantifiable outcome

  • CMV qPCR Kit Limit of Detection: 56 IU/mL
  • +3 more outcomes

Companies that use Idil Biotech

Customer profile

Segments2 records

Ideal customer profiles2 records

Idil Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Idil Biotech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Medical Technology and Biotechnology CompaniescoreStrategic or Co-development PartnerIdil Biotech offers comprehensive outsourcing services for molecular diagnostic solutions to medical technology and biotechnology companies. Services include concept design, assay development, manufacturing of prototypes and pilot batches, validation and stability studies, technical documentation, and certification assistance for CE submissions. Technology transfer of products in the portfolio is also possible.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Idil Biotech competitors and assessment

Company assessment

Direct peers

  • Anatolia Geneworks: Turkey-based molecular diagnostics company offering a broad IVD/CE-marked qPCR menu for infectious disease pathogens, HLA typing, and HPV genotyping - the closest head-to-head peer to Idil Biotech given shared geography, technology platform, and target customer (clinical labs in EMEA/Middle East).
  • Seegene: Korean molecular diagnostics specialist known for multiplex syndromic qPCR panels (respiratory, gastro, STI, meningitis/encephalitis) sold under its own brand and widely OEM-licensed - directly comparable to Idil's RevoDx multiplex pathogen panels on technology, menu, and OEM go-to-market model.
  • Bioeksen R&D Technologies: Turkey-based molecular diagnostics company producing CE-IVD qPCR kits and rapid molecular platforms (including the COVID-era Rapid Molecular Detection System) - directly comparable given shared Turkish base, IVD/CE-IVD positioning, and infectious disease menu overlap with RevoDx.
  • ELITech Group: European IVD manufacturer with a real-time PCR infectious disease menu, sample-preparation kits, and OEM/private-label capabilities - directly comparable to Idil on product architecture (qPCR kits + extraction reagents), CE-IVD positioning, and OEM contract manufacturing services.
  • Sacace Biotechnologies: Italy-based molecular diagnostics company selling CE-IVD qPCR kits for infectious diseases (HBV, HCV, HIV, STI, respiratory, meningitis) plus OEM manufacturing services - closely comparable mid-sized European peer with similar menu breadth and OEM go-to-market.

Broad incumbents

  • TIB Molbiol (Roche): Berlin-based molecular diagnostics specialist (now part of Roche Diagnostics) historically known for rapid development of qPCR assays for emerging pathogens and a deep infectious-disease menu - comparable on assay design philosophy and pathogen menu, though now distributed through Roche's global commercial engine.
  • DiaSorin: Italian-headquartered diagnostics multinational with a molecular business spanning qPCR kits, sample-to-answer systems (LIAISON MDX), and OEM partnerships - comparable on molecular IVD menu and EMEA footprint, though operating at much larger scale with proprietary instrumentation.
  • QIAGEN: Global molecular diagnostics and sample-preparation leader with the artus/QuantiFERON/QIAsymphony portfolio - overlaps with Idil on nucleic acid extraction kits (DirEXT vs QIAamp) and on parts of the infectious-disease qPCR menu, while operating at vastly larger scale through proprietary automation.

Emerging players

  • Vircell (Amplifon group): Spain-based molecular diagnostics and microbiology company offering qPCR infectious-disease kits and OEM capabilities - comparable European mid-market peer with overlapping IVD/CE-IVD molecular menu and similar reliance on distribution partners.
  • SolGent (KRIBB spinoff) / Kogene Biotech: Korean molecular diagnostics manufacturers producing CE-IVD/KFDA qPCR kits for infectious diseases (including SARS-CoV-2, respiratory, and enteric pathogens) and exporting globally - similar-sized Asian peers competing in the same overseas tender markets as Idil Biotech.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Idil Biotech compliance and trust

Trust signal

Compliance4 records

Idil Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Idil Biotech leadership team

Management profile

Number of profiles

Profiles1 record

Idil Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Idil Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Idil Biotech

What does Idil Biotech do?

Idil Biotech develops, manufactures, and sells the RevoDx brand of real-time PCR (qPCR) molecular diagnostic kits for detection of infectious disease pathogens (viruses, bacteria, fungi, parasites) across panels for high-risk viral pathogens, STIs, respiratory, gastrointestinal, sepsis, meningitis/encephalitis, transplant, TORCH, tropical diseases, herpes, HLA genetics, and drug resistance. The company also markets DirEXT nucleic acid extraction/purification reagents, qPCR research master mixes, and offers contract manufacturing, assay development, validation, and OEM technology transfer services to other diagnostics companies.

Is Idil Biotech a public or private company?

Idil Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Idil Biotech founded?

Idil Biotech was founded in 2019. It employs 1 to 10 people.

Where is Idil Biotech based?

Idil Biotech is headquartered in Istanbul.

How does Idil Biotech make money?

Four revenue lines are on record. Diagnostic Kit Sales are the primary driver. The others are purification Kit Sales, outsourcing Services and OEM Partnership.

Who are Idil Biotech's main competitors?

Direct peers on record are Anatolia Geneworks, Seegene, Bioeksen R&D Technologies, ELITech Group and Sacace Biotechnologies. Broad incumbents are TIB Molbiol (Roche), DiaSorin and QIAGEN. Emerging players are Vircell (Amplifon group) and SolGent (KRIBB spinoff) / Kogene Biotech.

Does Idil Biotech have an API?

No public API is recorded for Idil Biotech.

What industry is Idil Biotech in?

Idil Biotech's product category is Molecular Diagnostics (In Vitro Diagnostics). Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales